Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-062059
Filing Date
2025-05-01
Accepted
2025-05-01 17:41:29
Documents
2
Period of Report
2025-04-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1570
2 EX-24 ck0001798749-ex24.htm EX-24 10697
  Complete submission text file 0000950170-25-062059.txt   13831
Mailing Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 23, SUITE 105 WALTHAM MA 02453 (781) 312-3013
Jade Biosciences, Inc. (Issuer) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2001 MARKET STREET SUITE 2500 PHILADELPHIA PA 19103
Business Address
CAIN CHRISTOPHER W. (Reporting) CIK: 0001817733 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40544 | Film No.: 25904627